0,960  0,002  Antihypercholesterolemic
0,948  0,001  Cholesterol antagonist
0,944  0,003  TNF expression inhibitor
0,920  0,001  Pregnane X receptor agonist
0,920  0,001  UGT2B1 substrate
0,896  0,001  Antihyperlipoproteinemic
0,893  0,004  Respiratory analeptic
0,882  0,002  Anesthetic
0,884  0,004  Teratogen
0,877  0,002  Anesthetic general
0,872  0,001  UGT1A4 substrate
0,873  0,005  Embryotoxic
0,871  0,003  NOS3 expression inhibitor
0,871  0,004  Carcinogenic
0,869  0,006  CYP3A4 substrate
0,850  0,004  CYP2C19 substrate
0,846  0,004  UGT1A6 substrate
0,843  0,004  Bone diseases treatment
0,833  0,004  Hepatic disorders treatment
0,827  0,004  Antiosteoporotic
0,821  0,004  Lipoprotein disorders treatment
0,812  0,004  Analeptic
0,820  0,013  Antiinflammatory
0,810  0,005  Chemopreventive
0,802  0,002  UGT1A3 substrate
0,801  0,002  Hair growth stimulant
0,804  0,010  Caspase 9 stimulant
0,790  0,000  Cholesterol synthesis inhibitor
0,802  0,016  Apoptosis agonist
0,789  0,004  UDP-glucuronosyltransferase substrate
0,761  0,004  UGT1A1 substrate
0,760  0,005  Antiepileptic
0,745  0,002  Phospholipase C inhibitor
0,730  0,005  Proliferative diseases treatment
0,735  0,010  CYP2C9 substrate
0,716  0,001  UGT2B4 substrate
0,716  0,002  Antipruritic, allergic
0,711  0,002  Anticataract
0,714  0,006  NOS2 expression inhibitor
0,711  0,009  Chemoprotective
0,705  0,005  Hypolipemic
0,698  0,001  UGT2B7 substrate
0,697  0,004  Sulfotransferase substrate
0,693  0,004  Prostatic (benign) hyperplasia treatment
0,676  0,004  Sedative
0,670  0,001  Sodium/bile acid cotransporter inhibitor
0,670  0,009  Atherosclerosis treatment
0,682  0,023  Transcription factor NF kappa B inhibitor
0,655  0,005  Metabolic disease treatment
0,656  0,007  Antipsoriatic
0,648  0,011  Sensitization
0,654  0,019  Antidiabetic
0,654  0,019  Cyclophilin D inhibitor
0,630  0,003  Autism spectrum disorders treatment
0,628  0,005  Amyotrophic lateral sclerosis treatment
0,626  0,003  Retinoprotector
0,619  0,008  Apoptosis antagonist
0,638  0,029  Antineoplastic (breast cancer)
0,617  0,009  Inflammatory Bowel disease treatment
0,604  0,011  Cytotoxic
0,595  0,005  Renal disease treatment
0,590  0,002  Choleretic
0,591  0,005  Hepatoprotectant
0,583  0,002  UGT2B9 substrate
0,583  0,015  Immunosuppressant
0,564  0,002  Bile acid receptor antagonist
0,559  0,005  Muscle relaxant
0,565  0,012  Antifungal
0,548  0,003  Lipocortins synthesis antagonist
0,547  0,003  Prostate disorders treatment
0,547  0,003  Antiinfertility, female
0,547  0,004  Growth factor agonist
0,545  0,004  Antiacne
0,543  0,003  Abortion inducer
0,555  0,016  Immunomodulator
0,560  0,021  Immunostimulant
0,548  0,015  AR expression inhibitor
0,559  0,036  Antineoplastic (lung cancer)
0,536  0,014  Antihypertensive
0,527  0,005  Contraceptive
0,508  0,002  Antipruritic, non-allergic
0,505  0,007  Diuretic
0,502  0,006  Interferon gamma antagonist
0,524  0,034  Antibacterial
0,493  0,004  Liver cirrhosis treatment
0,509  0,021  CTGF expression inhibitor
0,490  0,003  Farnesoid X receptor antagonist
0,485  0,006  Antiparkinsonian, rigidity relieving
0,478  0,002  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,494  0,019  Antineoplastic (glioma)
0,478  0,004  Androgen antagonist
0,505  0,031  Prostate cancer treatment
0,478  0,005  Liver fibrosis treatment
0,491  0,025  Antineoplastic (melanoma)
0,483  0,017  Nitric oxide antagonist
0,469  0,004  DNA polymerase I inhibitor
0,475  0,012  Antineoplastic (liver cancer)
0,475  0,012  Antineoplastic (renal cancer)
0,477  0,017  Antineoplastic (glioblastoma multiforme)
0,480  0,023  Antineoplastic (pancreatic cancer)
0,479  0,030  Antineoplastic (ovarian cancer)
0,442  0,001  Anticholelithogenic
0,438  0,001  5-Alpha-reductase 2 inhibitor
0,438  0,002  5-Alpha-reductase inhibitor
0,447  0,027  UGT1A9 substrate
0,422  0,003  CDC25A inhibitor
0,421  0,001  5-Alpha-reductase 1 inhibitor
0,439  0,024  Antidiabetic (type 2)
0,428  0,015  Interleukin agonist
0,438  0,025  Cardiovascular analeptic
0,417  0,005  Antidiarrheal
0,429  0,018  Angiogenesis stimulant
0,458  0,047  Antiobesity
0,408  0,006  Antiviral (Influenza A)
0,403  0,004  Contraceptive female
0,449  0,050  Antileukemic
0,405  0,008  UGT2B15 substrate
0,393  0,002  Liver X receptor alpha agonist
0,399  0,008  Protein kinase stimulant
0,453  0,067  Alzheimer's disease treatment
0,395  0,011  Antiviral (Influenza)
0,407  0,025  Interleukin 2 agonist
0,405  0,025  Cardiodepressant
0,400  0,021  Antineoplastic (endocrine cancer)
0,380  0,003  Androgen agonist
0,373  0,004  LDLR expression enhancer
0,393  0,028  Antineoplastic (lymphoma)
0,398  0,035  Antioxidant
0,377  0,014  Platelet adhesion inhibitor
0,399  0,040  Antineoplastic (brain cancer)
0,364  0,008  Neurotrophic factor enhancer
0,359  0,003  UGT2B10 substrate
0,382  0,031  Hypoglycemic
0,357  0,006  Antifungal enhancer
0,365  0,018  Antiviral (Herpes)
0,347  0,001  Cholesterol absorption inhibitor
0,391  0,045  CYP2D6 substrate
0,391  0,047  Caspase 3 stimulant
0,381  0,044  Radioprotector
0,352  0,016  Male reproductive disfunction treatment
0,337  0,005  Hedgehog signaling inhibitor
0,337  0,006  Neurotrophic factor
0,375  0,050  ICAM1 expression inhibitor
0,348  0,026  Wound healing agent
0,323  0,003  Hyperparathyroidism treatment
0,311  0,001  Arachidonic acid antagonist
0,309  0,001  Vitamin D receptor agonist
0,330  0,030  Antineoplastic (sarcoma)
0,358  0,063  Antineoplastic (colorectal cancer)
0,286  0,002  Farnesoid X receptor agonist
0,302  0,021  Skeletal muscle relaxant
0,322  0,042  Heart failure treatment
0,286  0,007  Alcohol dehydrogenase substrate
0,329  0,050  Antineoplastic (multiple myeloma)
0,340  0,063  Antineoplastic (colon cancer)
0,278  0,003  Lanosterol 14 alpha demethylase inhibitor
0,272  0,002  RNA-directed RNA polymerase stimulant
0,274  0,004  Actinic keratosis treatment
0,272  0,003  Hypercalcemia treatment
0,274  0,007  Antineoplastic, alkylator
0,266  0,003  Glycine receptor agonist
0,283  0,021  Amylase inhibitor
0,265  0,006  Estrogen agonist
0,269  0,014  Psychosexual dysfunction treatment
0,257  0,002  UGT2B11 substrate
0,304  0,051  Cytostatic
0,308  0,055  Antineoplastic (cervical cancer)
0,256  0,006  ABCA1 expression enhancer
0,266  0,020  Antipruritic
0,244  0,004  Paget's disease treatment
0,273  0,033  Antialcoholic
0,271  0,035  P-glycoprotein inhibitor
0,257  0,024  Bone formation stimulant
0,272  0,039  RNA-directed DNA polymerase inhibitor
0,256  0,027  Diabetic nephropathy treatment
0,268  0,045  Antiviral (HIV)
0,235  0,013  Microtubule formation inhibitor
0,285  0,063  Cardiotonic
0,257  0,035  Diabetic retinopathy treatment
0,268  0,048  Antihypertriglyceridemic
0,217  0,001  Hedgehog signaling activator
0,229  0,021  Protein-tyrosine phosphatase 1B inhibitor
0,228  0,027  Toxic, respiratory center
0,203  0,002  Na+ K+ transporting ATPase inhibitor
0,202  0,002  Vitamin D receptor antagonist
0,201  0,004  Anabolic
0,252  0,056  EphB2 antagonist
0,198  0,004  Glycine receptor antagonist
0,205  0,012  Antineoplastic alkaloid
0,205  0,014  Growth stimulant
0,219  0,031  Interleukin 6 antagonist
0,258  0,072  Vascular (periferal) disease treatment
0,187  0,003  Anesthetic inhalation
0,259  0,075  DNA damaging
0,191  0,009  Postmenopausal disorders treatment
0,264  0,082  5 Hydroxytryptamine release stimulant
0,215  0,034  Acute respiratory distress syndrome (ARDS) treatment
0,184  0,004  Liver X receptor agonist
0,252  0,073  Myocardial infarction treatment
0,200  0,020  Endometrios treatment
0,214  0,038  VEGF expression inhibitor
0,238  0,065  Antiulcerative
0,187  0,016  Mucolytic
0,192  0,022  Expectorant
0,190  0,021  SULT1A1 substrate
0,244  0,076  Antiprotozoal (Leishmania)
0,245  0,077  Antidiabetic symptomatic
0,284  0,117  Stroke treatment
0,279  0,114  Calcium channel activator
0,208  0,044  Protein-tyrosine phosphatase inhibitor
0,177  0,013  Contraceptive male
0,174  0,014  Prolactin inhibitor
0,241  0,082  Antineoplastic (non-small cell lung cancer)
0,174  0,017  Estrogen antagonist
0,180  0,025  Antineoplastic antibiotic
0,156  0,006  CDC25B inhibitor
0,153  0,005  Sleep apnea treatment
0,263  0,116  Antithrombotic
0,241  0,095  Spasmolytic
0,197  0,052  Eye irritation, high
0,232  0,087  Antipyretic
0,144  0,001  Ileal bile acid transport inhibitor
0,145  0,005  Botulinum neurotoxin type A inhibitor
0,142  0,003  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,139  0,002  Glucose-6-phosphate dehydrogenase inhibitor
0,177  0,043  Skin whitener
0,138  0,004  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,197  0,069  Sleep disorders treatment
0,165  0,038  Proteasome inhibitor
0,202  0,075  Age-related macular degeneration treatment
0,219  0,093  Tumour necrosis factor alpha release inhibitor
0,139  0,013  Estrogen receptor alpha antagonist
0,138  0,020  SULT1E1 substrate
0,202  0,084  Antineoplastic enhancer
0,128  0,010  SULT1A2 substrate
0,159  0,042  Alkylator
0,189  0,073  Antihelmintic
0,187  0,072  Mutagenic
0,115  0,003  Lipocortins synthesis agonist
0,177  0,066  Antineoplastic (bone cancer)
0,168  0,058  NOS3 expression enhancer
0,156  0,046  Anesthetic local
0,125  0,017  Aromatase inhibitor
0,168  0,061  Melanin inhibitor
0,222  0,116  Gastrin inhibitor
0,109  0,003  Parathyroid hormone antagonist
0,152  0,046  Skin irritative effect
0,140  0,035  AMP-activated protein kinase stimulant
0,190  0,084  Insulin sensitizer
0,156  0,053  Adenylate cyclase stimulant
0,164  0,061  Insulin secretagoues
0,147  0,049  Aldehyde dehydrogenase inhibitor
0,109  0,011  Acetyl-CoA transferase inhibitor
0,124  0,028  Estrogen receptor beta antagonist
0,163  0,069  Uterine stimulant
0,101  0,007  Carbonic anhydrase IV inhibitor
0,212  0,118  Antituberculosic
0,102  0,009  Progesterone antagonist
0,095  0,003  Apical sodium codependent bile acid transporter inhibitor
0,095  0,004  Heparanase inhibitor
0,143  0,053  Antihemorrhagic
0,178  0,088  CYP2B6 inhibitor
0,218  0,130  CYP1A2 substrate
0,093  0,005  Glucocorticoid antagonist
0,209  0,124  Cardioprotectant
0,196  0,112  Antihypotensive
0,218  0,135  Antimycobacterial
0,131  0,048  GABA receptor agonist
0,090  0,007  Acetyl-CoA transferase 2 inhibitor
0,093  0,012  SULT2A1 substrate
0,090  0,009  Postcoital contraceptive
0,135  0,055  Antiviral (Hepatitis B)
0,186  0,107  VCAM1 expression inhibitor
0,200  0,123  DNA synthesis inhibitor
0,095  0,018  Phospholipase D inhibitor
0,086  0,011  Estrogen receptor alpha agonist
0,114  0,040  Posttraumatic stress disorder treatment
0,077  0,004  HMG CoA reductase inhibitor
0,177  0,105  Antiparasitic
0,112  0,041  Tourette's syndrome treatment
0,142  0,071  Antifungal (Cryptococcus)
0,098  0,027  Estrogen-related receptor beta agonist
0,165  0,095  Antiviral (Hepatitis)
0,144  0,075  Antidiabetic (type 1)
0,082  0,015  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,100  0,034  Antibiotic
0,205  0,141  Antihypoxic
0,071  0,007  Liver X receptor beta agonist
0,069  0,006  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,075  0,013  Mineralocorticoid receptor antagonist
0,065  0,004  CYP24 inhibitor
0,206  0,145  Hypoxia-inducible factor 1 alpha inhibitor
0,090  0,037  Keratolytic
0,068  0,016  Estrogen receptor beta agonist
0,095  0,044  Transcription factor NF kappa B stimulant
0,108  0,058  Protease inhibitor
0,171  0,122  Free radical scavenger
0,075  0,027  Nitric oxide donor
0,071  0,024  Heme oxygenase stimulant
0,170  0,126  Platelet antagonist
0,055  0,012  Acetyl-CoA transferase 1 inhibitor
0,089  0,048  Inducible nitric-oxide synthase inhibitor
0,060  0,020  Aldosterone antagonist
0,053  0,013  Hypogonadism treatment
0,071  0,031  Caspase 9 inhibitor
0,057  0,019  Microtubule stabilization
0,059  0,022  Potassium channel Kv1.3 blocker
0,071  0,035  HIV-1 integrase (Strand Transfer) inhibitor
0,079  0,044  Antitreponemal
0,053  0,019  Geranyltranstransferase inhibitor
0,044  0,011  Ceramide glucosyltransferase inhibitor
0,073  0,043  Premenstrual syndrome treatment
0,039  0,009  Estrone sulfatase inhibitor
0,070  0,040  Andropause treatment
0,035  0,006  1,3-Beta-glucan synthase inhibitor
0,034  0,005  Corticosteroid-like
0,136  0,109  Muscular dystrophy treatment
0,032  0,006  Progesterone agonist
0,119  0,095  Lipid peroxidase inhibitor
0,117  0,094  Vanilloid 1 agonist
0,106  0,083  Menstruation disorders treatment
0,097  0,074  Toll-Like receptor 4 antagonist
0,082  0,059  GABA A receptor agonist
0,044  0,021  GABA uptake inhibitor
0,199  0,177  Vasodilator, peripheral
0,025  0,004  Telomerase stimulant
0,022  0,003  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,109  0,090  Cyclooxygenase 3 inhibitor
0,103  0,084  Carcinogenic, group 3
0,063  0,046  Interferon inducer
0,045  0,028  Opioid kappa receptor agonist
0,094  0,079  HDL-cholesterol increasing
0,077  0,062  Opioid kappa receptor antagonist
0,138  0,123  ATPase inhibitor
0,129  0,115  Aldose reductase substrate
0,021  0,007  Glucocorticoid agonist
0,015  0,002  Transcortin receptor antagonist
0,051  0,039  Protein 50S ribosomal subunit inhibitor
0,033  0,022  Carboxypeptidase B inhibitor
0,011  0,001  Vitamin D-like
0,077  0,068  Antiprotozoal activity enhancer
0,051  0,044  GABA receptor antagonist
0,033  0,026  Tubulin agonist
0,040  0,035  HIV-1 protease inhibitor
0,120  0,117  Phospholipase A2 inhibitor
0,216  0,214  CYP2C19 inhibitor
0,047  0,045  Cathepsin D inhibitor
0,031  0,030  Renin inhibitor

